Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
From conventional to atypical antipsychotics and back: Dynamic processes in the diffusion of new medications
Douglas Leslie
, Robert A. Rosenheck
Department of Public Health Sciences
Department of Psychiatry and Behavioral Health
Division of Health Services and Behavioral Research
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Research output
:
Contribution to journal
›
Article
›
peer-review
72
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'From conventional to atypical antipsychotics and back: Dynamic processes in the diffusion of new medications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
New Drugs
100%
Antipsychotics
100%
Dynamic Process
100%
Atypical Antipsychotics
100%
Quetiapine
100%
Schizophrenia
66%
Clozapine
66%
Time Elapsed
33%
Schizophrenia Treatment
33%
Pharmacotherapy
33%
National Health System
33%
Olanzapine
33%
Patients with Schizophrenia
33%
Department of Veterans Affairs
33%
Veterans Affairs
33%
Formulary
33%
Drug Regimen
33%
Prescription Pattern
33%
Neuroscience
Atypical Antipsychotic
100%
Quetiapine
100%
Antipsychotic
100%
Clozapine
66%
Olanzapine
33%
Treatment of Schizophrenia
33%
Drug Therapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Atypical Antipsychotics
100%
Quetiapine
100%
Clozapine
66%
Pharmacotherapy
33%
Olanzapine
33%